Who owns Orakl Oncology?

Orakl Oncology is currently owned by Singular Capital Partners, through Singular Ventures II, since 2024.

When did Singular Capital Partners acquire Orakl Oncology?

Singular Capital Partners acquired Orakl Oncology in 2024 (active for 2 years).

Healthcare·

France·Active·2yr hold

Orakl Oncology is a healthcare company, headquartered in France.

Entry

2024

Hold

2yr

Status

Active

Est. EV

–

Most recent investor

2 ownership periods

HQFrance

SectorHealthcare

Villejuif AI oncology drug-discovery spinoff from Gustave Roussy 2023; Singular led EUR 11M seed December 2024.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Singular Ventures II

6 comparable healthcare deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings